Cost Effectiveness of Metal Stents in Pancreatic Cancer

ASCO Gastrointestinal Cancers Symposium
Cancer, Cost Effectiveness Analysis, Economic Models, Oncology, Pancreatic Cancer

Cost-effectiveness of Cetuximab as first-line treatment for metastatic colorectal cancer in the US

ISPOR Annual International Meeting
Cancer, Colorectal Cancer, Cost Effectiveness Analysis, Economic Models, Oncology

The Impact of 5-HT3RA Use on Cost and Utilization in Patients with Chemotherapy- Induced Nausea and Vomiting: Systematic Review of the Literature

American Health & Drug Benefits
Cancer, Chemotherapy-induced Nausea and Vomiting, Oncology, Systematic Review

Incidence and cost of treatment-emergent comorbid events in insured patients with chronic hepatitis C virus infection: a retrospective cohort study

BMC Health Services Research
Epidemiology, Hepatitis C, Hepatology, Insurance Claims, Secondary Data Analysis

Cost–effectiveness of bronchial thermoplasty in commercially-insured patients with poorly controlled, severe, persistent asthma

Expert Review of Pharmacoeconomics and Outcomes Research

Cost Effectiveness of Treatments After Failure of a First-Line Hypomethylating Agent in Myelodysplastic Syndromes (MDS)

American Society of Hematology 56th Annual Meeting
Cancer, Cost Effectiveness Analysis, Economic Models, Hematology, Myelodysplastic Syndrome

The Healthcare and Economic Impact of Diarrhea in US Patients with Carcinoid Syndrome

NANETS Neuroendocrine Tumor Symposium
Cancer, Carcinoid Syndrome, Gastroenterology, Insurance Claims, Neuroendocrine Tumors, Oncology, Secondary Data Analysis